
                                SEQUENCE LISTING

<110> Karanicolas, John
      Khowsathit, Jittasak
      Salvino, Joseph
      Yeggoni, Daniel Pushparaju
      Miller, Sven

<120> COMPOSITIONS AND METHODS FOR MODULATION
  OF ANTIBODY ACTIVITY

<130> 0149-P06829WO00

<150> 63/162,208          
<151> 2021-03-17  

<160> 30

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = tetrahydro-isoquinoline-3-carboxylic acid

<400> 1
Tyr Xaa Ser Asp
 1              


<210> 2
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = tetrahydro-isoquinoline-3-carboxylic acid

<400> 2
Arg Xaa Ser Asp
 1              


<210> 3
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<220> 
<221> VARIANT        
<222> 1
<223> Xaa = diaminopimelic acid (Dap)

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Ornithine (Orn)

<220> 
<221> VARIANT        
<222> 3
<223> Xaa = Phe(3-Cl)

<220> 
<221> VARIANT        
<222> 4
<223> Xaa = Cys(MeOBzl)

<400> 3
Xaa Xaa Xaa Xaa
 1              


<210> 4
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<220> 
<221> VARIANT        
<222> 1
<223> Xaa = Diaminopimelic acid (Dap)

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Ornithine (Orn)

<220> 
<221> VARIANT        
<222> 3
<223> Xaa = Phe(3-Cl)

<220> 
<221> VARIANT        
<222> 4
<223> Xaa = Nle(OBzl)

<400> 4
Xaa Xaa Xaa Xaa
 1              


<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 5
His Arg Phe Arg
 1              


<210> 6
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 6
Thr Gly Arg Gly Pro Ser Trp Val
 1               5              


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 7
Gly Ser Gly Arg Ser Ala Gly
 1               5          


<210> 8
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 8
Gly Gly Ser Gly Arg Ser Ala Asn Ala Lys Cys
 1               5                  10      


<210> 9
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 9
Leu Gly Gly Ser Gly Arg Ser Ala Asn Ala Ile Leu Glu
 1               5                  10              


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 10
Leu Ser Gly Arg Ser Asp Asn His
 1               5              


<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 11
Leu Ser Gly Arg Asp Asn His
 1               5          


<210> 12
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 12
Gly Phe Leu Gly
 1              


<210> 13
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 13
Phe Arg Arg Gly
 1              


<210> 14
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 14
Gly Pro Leu Gly Val
 1               5  


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 15
Gly Pro Leu Gly Val Arg Gly
 1               5          


<210> 16
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 16
Pro Val Gly Leu Ile Gly
 1               5      


<210> 17
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = citrulline (Cit)

<220> 
<221> VARIANT        
<222> 4
<223> Xaa = homophenylalanine (Hof)

<400> 17
Pro Xaa Gly Xaa Tyr Leu
 1               5      


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 18
Gly Pro Leu Gly Leu Ala Gly
 1               5          


<210> 19
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 19
Gly Pro Leu Gly Val Ala Gly Leu
 1               5              


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 20
Gly Pro Leu Gly Ile Ala Gly Gln
 1               5              


<210> 21
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 21
Gly Pro Val Gly Leu Ile Gly Lys
 1               5              


<210> 22
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 22
Pro Leu Gly Leu
 1              


<210> 23
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 23
Ser Leu Ala Pro Leu Gly Leu Gln Arg Arg
 1               5                  10  


<210> 24
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Substrate

<400> 24
Gly Arg Ile Gly Phe Leu Arg Thr Ala Lys Gly Gly
 1               5                  10          


<210> 25
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> antibody sequence

<220> 
<221> VARIANT        
<222> 2, 6
<223> Xaa = any amino acid

<400> 25
Pro Xaa Thr Phe Gly Xaa Gly
 1               5          


<210> 26
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> antibody sequence

<220> 
<221> VARIANT        
<222> 1, 2, 5, 7
<223> Xaa = any amino acid

<400> 26
Xaa Xaa Trp Val Xaa Gln Xaa
 1               5          


<210> 27
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> antibody sequence

<220> 
<221> VARIANT        
<222> 1, 3, 6
<223> Xaa = any amino acid

<400> 27
Xaa Asp Xaa Trp Gly Xaa Gly
 1               5          


<210> 28
<211> 109
<212> PRT
<213> Artificial Sequence

<220> 
<223> antibody sequence

<400> 28
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Gly Ser Ser
            20                  25                  30          
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45              
Ile Tyr Gly Ala Phe Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60                  
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65                  70                  75                  80  
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
                85                  90                  95      
Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
            100                 105                 


<210> 29
<211> 118
<212> PRT
<213> Artificial Sequence

<220> 
<223> antibody sequence

<400> 29
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Thr Phe Ile Ser Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys
                85                  90                  95      
Ala Arg Thr Gly Trp Leu Gly Pro Phe Asp Tyr Trp Gly Gln Gly Thr
            100                 105                 110         
Leu Val Thr Val Ser Ser
        115             


<210> 30
<211> 29
<212> PRT
<213> Artificial Sequence

<220> 
<223> linker sequence

<400> 30
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
 1               5                  10                  15      
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
            20                  25                  

